Cryptocurrency & Digital Assets

Viral beauty brand SACHEU brings its full line of "life-proof" makeup to Target, a move redefining the path from TikTok fame to retail dominance.

A landmark partnership between Grassroots Carbon and Colorado State University is set to validate soil carbon removal, impacting ranchers and corporations.

The new 'Suppies' awards aim to simplify the confusing supplement market, but do they offer true clarity or just clever marketing? We investigate.

Toymaker JAKKS Pacific launches an ambitious new platform targeting the multi-billion dollar anime, manga, and creator markets. Can it beat the competition?

Mopec Group appoints Scott Nudelman to lead its new Certified Service division, a strategic move to boost lab uptime and gain a competitive edge.

How a consumer-voted award for Jumex's new drink signals a major shift in the multi-billion dollar hydration industry and a new era for the legacy brand.

Argentina's Entre Ríos province launches a cash offer to buy back 2028 notes, funded by a new bond, aiming to ease debt and boost investment.

Chime Enterprise's growth signals a major shift as firms see employee financial health as key to productivity, moving beyond simple earned wage access.

Most hospitals have static defenses ill-equipped for modern threats. A new, free framework offers a clinically-informed path to a dynamic Zero Trust posture.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

At a key industry summit, Sutro Biopharma showcases its next-gen ADC platform, designed to overcome treatment resistance with "supercharged" dual-payload drugs.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

Insulation giant PrimaLoft taps a BOA Technology veteran as its new president, signaling a strategic push for commercial growth in the sustainable materials sector.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

Light Source Communications is building a massive underground dark fiber network to connect St. Louis and Tulsa, powering the AI revolution in the heartland.

A landmark FDA approval for Bracco's VUEWAY allows high-quality MRI scans in neonates with half the standard gadolinium dose, easing safety concerns.

C4 Therapeutics begins a crucial study for its oral protein degrader, cemsidomide, offering new hope for heavily treated multiple myeloma patients.

A new partnership integrates FranklinWH home batteries with WeaveGrid's software, letting utilities tap into residential power to stabilize the grid.